Drug Shortage Report for PHENYTOIN SODIUM
Report ID | 49377 |
Drug Identification Number | 02460912 |
Brand name | APO-PHENYTOIN SODIUM |
Common or Proper name | PHENYTOIN |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PHENYTOIN SODIUM |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-05-14 |
Estimated end date | 2018-09-14 |
Actual end date | 2018-08-30 |
Shortage status | Resolved |
Updated date | 2018-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-08-31 | French | Compare |
v5 | 2018-08-31 | English | Compare |
v4 | 2018-06-11 | French | Compare |
v3 | 2018-06-11 | English | Compare |
v2 | 2018-05-15 | French | Compare |
v1 | 2018-05-15 | English | Compare |
Showing 1 to 6 of 6